Log in

Relevant bibliographies by topics / Severe Actute Respiratory Syndrome (SARS)

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Severe Actute Respiratory Syndrome (SARS)'

Author: Grafiati

Published: 29 July 2024

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Severe Actute Respiratory Syndrome (SARS).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Severe Actute Respiratory Syndrome (SARS)"

1

Fielding, James E., Keflemar Yohannes, Hassan Vally, and Jenean D. Spencer. "Severe acute respiratory syndrome surveillance in Australia." Communicable Diseases Intelligence 28 (June 30, 2004): 181–86. https://doi.org/10.33321/cdi.2004.28.15.

Full text

Abstract:

In March 2003, the World Health Organization (WHO) issued a global alert recommending active worldwide surveillance for severe acute respiratory syndrome (SARS). This paper describes the epidemiological features of cases reported by Australian states and territories to the Australian Government Department of Health and Ageing between 17 March and 31 July 2003. There were 138 people investigated for SARS: 111 as suspect and 27 as probable. Five probable cases were reported to WHO after review of other possible diagnoses and Australia-specific exclusion criteria had been applied. An additional p

APA, Harvard, Vancouver, ISO, and other styles

2

Ivanov, Konstantin A., Volker Thiel, Jessika C. Dobbe, Yvonne van der Meer, Eric J. Snijder, and John Ziebuhr. "Multiple Enzymatic Activities Associated with Severe Acute Respiratory Syndrome Coronavirus Helicase." Journal of Virology 78, no. 11 (2004): 5619–32. http://dx.doi.org/10.1128/jvi.78.11.5619-5632.2004.

Full text

Abstract:

ABSTRACT Severe acute respiratory syndrome coronavirus (SARS-CoV), a newly identified group 2 coronavirus, is the causative agent of severe acute respiratory syndrome, a life-threatening form of pneumonia in humans. Coronavirus replication and transcription are highly specialized processes of cytoplasmic RNA synthesis that localize to virus-induced membrane structures and were recently proposed to involve a complex enzymatic machinery that, besides RNA-dependent RNA polymerase, helicase, and protease activities, also involves a series of RNA-processing enzymes that are not found in most other

APA, Harvard, Vancouver, ISO, and other styles

3

A El-Masry, Eman. "Immunization against severe acute respiratory syndrome Coronavirus 2: an overview." African Health Sciences 21, no. 4 (2021): 1574–83. http://dx.doi.org/10.4314/ahs.v21i4.11.

Full text

Abstract:

In the past years, numerous new fatal infections have emerged, including Ebola, Nipah, and Zika viruses, as well as coronaviruses. Recently, infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged in China, and were then transmitted all over the world, causing the coronavirus disease-19 (COVID-19) pandemic, which is transmitted at a higher rate than other diseases caused by coronaviruses. At the time of writing this review, COVID-19 is not contained in most countries in spite of quarantine, physical distancing, and enhanced hygiene measures. In this review, I

APA, Harvard, Vancouver, ISO, and other styles

4

Zoghi, Sina, Hossein Jafari Khamirani, Seyed Alireza Dastgheib, Mehdi Dianatpour, and Alireza Ghaffarieh. "An analysis of inhibition of the severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase by zinc ion: an in silico approach." Future Virology 16, no. 5 (2021): 331–39. http://dx.doi.org/10.2217/fvl-2020-0369.

Full text

Abstract:

Background: Coronavirus disease 2019 is caused by exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was reported that Zn2+ is an inhibitor of severe acute respiratory syndrome coronavirus (SARS-CoV). We hypothesize that the same applies to the newly discovered SARS-CoV-2. Material & methods: We compared the structure of RNA-dependent RNA polymerase between SARS-CoV and SARS-CoV-2. The RdRp’s binding to Zn2+ was studied by metal ion-binding site prediction and docking server. Results: Several regions containing key residues were detected. The functional aspartic a

APA, Harvard, Vancouver, ISO, and other styles

5

Lamirande, Elaine W., Marta L. DeDiego, Anjeanette Roberts, et al. "A Live Attenuated Severe Acute Respiratory Syndrome Coronavirus Is Immunogenic and Efficacious in Golden Syrian Hamsters." Journal of Virology 82, no. 15 (2008): 7721–24. http://dx.doi.org/10.1128/jvi.00304-08.

Full text

Abstract:

ABSTRACT The immunogenicity and protective efficacy of a live attenuated vaccine consisting of a recombinant severe acute respiratory syndrome (SARS) coronavirus lacking the E gene (rSARS-CoV-ΔE) were studied using hamsters. Hamsters immunized with rSARS-CoV-ΔE developed high serum-neutralizing antibody titers and were protected from replication of homologous (SARS-CoV Urbani) and heterologous (GD03) SARS-CoV in the upper and lower respiratory tract. rSARS-CoV-ΔE-immunized hamsters remained active following wild-type virus challenge, while mock-immunized hamsters displayed decreased activity.

APA, Harvard, Vancouver, ISO, and other styles

6

Fylenko, B. M., V. I. Babenko, N. V. Royko, I. I. Starchenko, S. A. Proskurnya, and A. O. Byelyayeva. "Morphological Manifestations of COVID-19-Associated Pneumonia." Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 7, no. 2 (2022): 82–87. http://dx.doi.org/10.26693/jmbs07.02.082.

Full text

Abstract:

The purpose of study was to study the pathomorphological changes of COVID-19-associated pneumonia in its severe course on the basis of autopsies with substantiation of pathogenetic links of clinical and morphological manifestations. Materials and methods. The study of changes of COVID-19-associated pneumonia in its severe course was performed on the basis of autopsies of 16 deceased individuals using macroscopic and microscopic methods. All patients had chronic diseases during their lifetime, which contributed to the severe course of COVID-19. Results and discussion. The severe course of COVID

APA, Harvard, Vancouver, ISO, and other styles

7

Isnaini, Nadia, Khairan Khairan, Meutia Faradhilla, et al. "A Study of Essential Oils from Patchouli (Pogostemon cablin Benth.) and Its Potential as an Antivirus Agent to Relieve Symptoms of COVID-19." Journal of Patchouli and Essential Oil Products 1, no. 2 (2022): 27–35. http://dx.doi.org/10.24815/jpeop.v1i2.23763.

Full text

Abstract:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new type of virus that attacks the respiratory system and has caused the global epidemic of coronavirus disease 2019 (COVID-19). Some persons who are infected with this virus develop symptoms ranging from a typical cold to fever to more severe illnesses, such as Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). The development of a SARS-CoV-2 vaccine is being actively researched but will likely take more than a year to become available to the general public. As a result, numerous researchers a

APA, Harvard, Vancouver, ISO, and other styles

8

Mostafa, Ahmed, Ahmed Kandeil, Yaseen A. M. M. Elshaier, et al. "FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2." Pharmaceuticals 13, no. 12 (2020): 443. http://dx.doi.org/10.3390/ph13120443.

Full text

Abstract:

(1) Background: Drug repositioning is an unconventional drug discovery approach to explore new therapeutic benefits of existing drugs. Currently, it emerges as a rapid avenue to alleviate the COVID-19 pandemic disease. (2) Methods: Herein, we tested the antiviral activity of anti-microbial and anti-inflammatory Food and Drug Administration (FDA)-approved drugs, commonly prescribed to relieve respiratory symptoms, against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the viral causative agent of the COVID-19 pandemic. (3) Results: Of these FDA-approved antimicrobial drugs, Azith

APA, Harvard, Vancouver, ISO, and other styles

9

Poutanen, Susan M., Mary Vearncombe, Allison J. McGeer, Michael Gardam, Grant Large, and Andrew E. Simor. "Nosocomial Acquisition of Methicillin-ResistantStaphylococcus aureusDuring an Outbreak of Severe Acute Respiratory Syndrome." Infection Control & Hospital Epidemiology 26, no. 2 (2005): 134–37. http://dx.doi.org/10.1086/502516.

Full text

Abstract:

AbstractObjective:The four hospitals assessed in this study use active surveillance cultures for methicillin-resistantStaphylococcus aureus(MRSA) and contact precautions for MRSA-positive patients as part of routine infection control practices. The objective of this study was to determine whether nosocomial acquisition of MRSA decreased in these hospitals during an outbreak of severe acute respiratory syndrome (SARS) when barrier precautions were routinely used for all patients.Design:Retrospective cohort study.Setting:Three tertiary-care hospitals (a 1,100-bed hospital; a 500-bed hospital; an

APA, Harvard, Vancouver, ISO, and other styles

10

Rha, Brian, Joana Y. Lively, Janet A. Englund, et al. "Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children: Multicenter Surveillance, United States, January–March 2020." Journal of the Pediatric Infectious Diseases Society 9, no. 5 (2020): 609–12. http://dx.doi.org/10.1093/jpids/piaa075.

Full text

Abstract:

Abstract Previous reports of coronavirus disease 2019 among children in the United States have been based on health jurisdiction reporting. We performed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing on children enrolled in active, prospective, multicenter surveillance during January–March 2020. Among 3187 children, only 4 (0.1%) SARS-CoV-2–positive cases were identified March 20–31 despite evidence of rising community circulation.

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Severe Actute Respiratory Syndrome (SARS)"

1

Chu, Chung-ming. "Clinical aspects of severe acute respiratory syndrome (SARS)." Click to view the E-thesis via HKUTO, 2005. http://sunzi.lib.hku.hk/hkuto/record/B31937925.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Chu, Chung-ming, and 朱頌明. "Clinical aspects of severe acute respiratory syndrome (SARS)." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2005. http://hub.hku.hk/bib/B31937925.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Lau, Yik-Chung. "Numerical simulation of severe acute respiratory syndrome (SARS) epidemics /." View abstract or full-text, 2004. http://library.ust.hk/cgi/db/thesis.pl?PHYS%202004%20LAU.

Full text

Abstract:

Thesis (M. Phil.)--Hong Kong University of Science and Technology, 2004.<br>Includes bibliographical references (leaves 43-44). Also available in electronic version. Access restricted to campus users.

APA, Harvard, Vancouver, ISO, and other styles

4

Chauhan, Vinita Singh. "Molecular characterization of severe acute respiratory syndrome (SARS) coronavirus - nucleocapsid protein." Diss., Manhattan, Kan. : Kansas State University, 2006. http://hdl.handle.net/2097/152.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Ching, Chi-yun Johannes. "Study of host genetic susceptibility to severe acute respiratory syndrome (SARS) infection." Click to view the E-thesis via HKUTO, 2008. http://sunzi.lib.hku.hk/hkuto/record/B40687648.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Ching, Chi-yun Johannes, and 程子忻. "Study of host genetic susceptibility to severe acute respiratory syndrome (SARS) infection." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B40687648.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Chow, Yan-ching Ken, and 周恩正. "Characterization of the apoptotic properties of severe acute respiratory syndrome coronavirus (SARS-CoV) structural proteins." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2004. http://hub.hku.hk/bib/B30105493.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Law, Ka-man. "Vaccine development against the severe acute respiratory syndrome-coronavirus (SARS-CoV) using SARS-CoV spike protein." Click to view the E-thesis via HKUTO, 2005. http://sunzi.lib.hku.hk/hkuto/record/B36774480.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Law, Ka-man, and 羅嘉敏. "Vaccine development against the severe acute respiratory syndrome-coronavirus (SARS-CoV) using SARS-CoV spike protein." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2005. http://hub.hku.hk/bib/B36774480.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Ng, Yuen-yi Fiona. "Assessment of quality of life in adults recovering from severe acute respiratory syndrome /." Click to view the E-thesis via HKUTO, 2004. http://sunzi.lib.hku.hk/hkuto/record/B31972998.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Severe Actute Respiratory Syndrome (SARS)"

1

Okeyo, T. M. Family education handbook on SARS, Severe Acute Respiratory Syndrome. Centre for Quality in Healthcare Organization, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

S, Griffen Ashley, ed. Progress in SARS research. Nova Science Publishers, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Serradell, Joaquima. SARS. 2nd ed. Chelsea House, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Serradell, Joaquima. SARS. 2nd ed. Edited by Babcock Hilary. Chelsea House, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Serradell, Joaquima. SARS. 2nd ed. Edited by Babcock Hilary. Chelsea House, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Sujudi, Achmad. Menangkal badai: Pengalaman mencegah ancaman severe acute respiratory syndrome (SARS) tahun 2003. Departemen Kesehatan R.I., 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Severe acute respiratory syndrome (SARS): Hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, first session on examining the status of the severe acute respiratory syndrome threat, April 29, 2003. U.S. G.P.O., 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Arthur, Kleinman, and Watson James L, eds. SARS in China: Prelude to pandemic? Stanford University Press, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

1939-, Wong John, and Zheng Yongnian, eds. The SARS epidemic: Challenges to China's crisis management. World Scientific, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Ahuja, Anil T. Imaging in SARS. GMM, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Severe Actute Respiratory Syndrome (SARS)"

1

Leung, CW. "SARS in Children." In Severe Acute Respiratory Syndrome. Blackwell Publishing Ltd, 2008. http://dx.doi.org/10.1002/9780470755952.ch4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Ooi, Clara GC. "Radiology of SARS." In Severe Acute Respiratory Syndrome. Blackwell Publishing Ltd, 2008. http://dx.doi.org/10.1002/9780470755952.ch6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Peiris, Malik, and Albert DME Osterhaus. "Aetiology of SARS." In Severe Acute Respiratory Syndrome. Blackwell Publishing Ltd, 2008. http://dx.doi.org/10.1002/9780470755952.ch7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Heymann, David L. "SARS: A Global Perspective." In Severe Acute Respiratory Syndrome. Blackwell Publishing Ltd, 2008. http://dx.doi.org/10.1002/9780470755952.ch2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Hayden, Frederick G., and Mark R. Denison. "Antiviral Agents for SARS." In Severe Acute Respiratory Syndrome. Blackwell Publishing Ltd, 2008. http://dx.doi.org/10.1002/9780470755952.ch20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Drosten, C., KH Chan, and LLM Poon. "Viral Diagnosis of SARS." In Severe Acute Respiratory Syndrome. Blackwell Publishing Ltd, 2008. http://dx.doi.org/10.1002/9780470755952.ch9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Guan, Yi, Hume Field, Gavin JD Smith, and Honglin Chen. "SARS Coronavirus: An Animal Reservoir?" In Severe Acute Respiratory Syndrome. Blackwell Publishing Ltd, 2008. http://dx.doi.org/10.1002/9780470755952.ch11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Merianos, Angela, Robert Condon, Hitoshi Oshitani, Denise Werker, and Roberta Andraghetti. "Epidemiology and Transmission of SARS." In Severe Acute Respiratory Syndrome. Blackwell Publishing Ltd, 2008. http://dx.doi.org/10.1002/9780470755952.ch13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Kamieński, Łukasz. "Severe Acute Respiratory Syndrome (SARS)." In The Palgrave Encyclopedia of Global Security Studies. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-74336-3_555-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Peiris, J. S. M., Y. Guan, L. L. M. Poon, V. C. C. Cheng, J. M. Nicholls, and K. Y. Yuen. "Severe Acute Respiratory Syndrome (SARS)." In Emerging Infections 7. ASM Press, 2014. http://dx.doi.org/10.1128/9781555815585.ch2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Severe Actute Respiratory Syndrome (SARS)"

1

Huang, Yuxia. "Modeling the severe acute respiratory syndrome (SARS) outbreak in Beijing." In the 1st International Conference and Exhibition. ACM Press, 2010. http://dx.doi.org/10.1145/1823854.1823895.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

BURIOT, DIEGO. "HEALTH AND SECURITY SEVERE ACUTE RESPIRATORY SYNDROME (SARS): TAKING A NEW THREAT SERIOUSLY." In Fourth Centenary of the Foundation of the First Academy of Sciences: “Academia Lynceorum” by Federico Cesi and Pope Clemente VIII. WORLD SCIENTIFIC, 2004. http://dx.doi.org/10.1142/9789812702753_0023.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Quinn, R., M. Liu, Y. Gu, T. Mak, and E. Belden. "Keynote Lecture “Anti-viral Drug Discovery for Severe Acute Respiratory Syndrome (SARS-CoV-2)”." In GA – 70th Annual Meeting 2022. Georg Thieme Verlag KG, 2022. http://dx.doi.org/10.1055/s-0042-1758917.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Amorim, Maria Clara Carvalho Silva de, Karla Oliveira Couto, Pedro José da Silva Júnior, Thiago Gonçalves Fukuda, Pedro Antônio Pereira de Jesus, and Mateus Santana do Rosário. "Hemisferic encephalic involviment associated with sars- cov-2." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.005.

Full text

Abstract:

Context: The novel severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) emerged in Wuhan, China and rapidly spread worldwide. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are being recognised increasingly. Case report: In this report, we demonstrate a case of hemispheric brain in volvement as a neurological manifestation of Sars-cov-2 in a 74-year-old patient admitted to Hospital Santa Izabel (HSI) between May and July 2020. Conclusion: In COVID-19, although the predominant clinical presentation is with respiratory disease, neur

APA, Harvard, Vancouver, ISO, and other styles

5

Lazarus, Theophilus. "SARS-CoV-2 infection and neuropsychological outcomes." In 2nd International Neuropsychological Summer School named after A. R. Luria “The World After the Pandemic: Challenges and Prospects for Neuroscience”. Ural University Press, 2020. http://dx.doi.org/10.15826/b978-5-7996-3073-7.10.

Full text

Abstract:

The entire world is currently confronted with the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS.CoV.2), a novel betacoronavirus causing the deadly pandemic of coronavirus disease 2019 (COVID.19). Since there is now increasing reports of neurological and cognitive problems, the impact of COVID.19 on neuropsychological functioning is unknown but is likely to leave residual problems.

APA, Harvard, Vancouver, ISO, and other styles

6

Redondo Galán, C., M. Ferris Villanueva, D. González Vaquero, MD Rivas Rodríguez, and JF Rangel Mayoral. "5PSQ-172 Experience with tocilizumab in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection." In 25th Anniversary EAHP Congress, Hospital Pharmacy 5.0 – the future of patient care, 23–28 March 2021. British Medical Journal Publishing Group, 2021. http://dx.doi.org/10.1136/ejhpharm-2021-eahpconf.291.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Legband, Nathan, Jameel Feshitan, Mark Borden, and Benjamin Terry. "Living Without Breathing: A Study in Extrapulmonary Respiration Using a Novel Oxygen Carrier." In ASME 2013 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/sbc2013-14735.

Full text

Abstract:

Pulmonary failure results when the lungs experience significant damage and are unable to supply the body and brain with oxygen. Pulmonary failure has many causes including lung cancer, physical trauma, acute respiratory distress syndrome (ARDS), aerosolized bioterrorism agents and diseases such as severe acute respiratory syndrome (SARS), pneumonia, and tuberculosis [1,2].

APA, Harvard, Vancouver, ISO, and other styles

8

Araújo, Poliana Rafaela dos Santos, Kauan Alves Sousa Madruga, Bruna Alves Rocha, and Lucas Oliveira Braga. "Neurological manifestations associated with SARS-CoV-2 infection: a narrative review." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.442.

Full text

Abstract:

Background: Coronavirus disease (COVID-19), once identified, soon spread globally, becoming a pandemic. Although patients present mainly with respiratory complaints, several neurological symptoms have been reported. Symptoms range from headache and nonspecific dizziness to seizures and cerebrovascular disease (CVD). It has also been shown that the severity of the infection is directly proportional to the development of neurological symptoms, especially CVD and changes in mental status. Objective: The present study aims to briefly review the neurological manifestations of COVID-19 and discuss t

APA, Harvard, Vancouver, ISO, and other styles

9

Makoba, J., H. Addai-Boateng, and R. S. Silverman. "A Case Report of Tracheal Stenosis After Intubation for Severe SARS-CoV-2 Pneumonia/Acute Respiratory Distress Syndrome." In American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA. American Thoracic Society, 2024. http://dx.doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a6407.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Sidorova, A. P., and A. V. Bakunovich. "ANTIRETROVIRAL DRUGS AS POTENTIAL INHIBITORS OF SARS-COV-2 Mpro." In SAKHAROV READINGS 2022: ENVIRONMENTAL PROBLEMS OF THE XXI CENTURY. International Sakharov Environmental Institute of Belarusian State University, 2022. http://dx.doi.org/10.46646/sakh-2022-2-31-34.

Full text

Abstract:

Ritonavir, nelfinavir and lopinavir are a group of protease inhibitors. These inhibitors are widely used in combination with other protease inhibitors in the therapy and prevention of human immunodeficiency virus. Also, the combination of these inhibitors seems to be an effective therapeutic agent that can affect the main protease of Mpro coronavirus and, thus, provide long-term suppression of viral load in the disease of severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2).

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Severe Actute Respiratory Syndrome (SARS)"

1

Fuller, Julie, Keith Hanley, Robert Schultz, et al. Surveillance for Respiratory Infections, Including Severe Acute Respiratory, Syndrome (SARS), in Cobra Gold 2003. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada455915.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Goren, Talia, Itai Beeri, and Dana Rachel vashdi. Trust in government and compliance with health instructions during respiratory epidemics and pandemics: A systematic review protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.10.0041.

Full text

Abstract:

Review question / Objective: We will use the Condition-Context-Population (CoCoPop) framework (Munn et al., 2015) in this review, which aims to explore the following question: Do the features of respiratory epidemics and pandemics (e.g., magnitude, duration) impact the associations between (types of) trust in government and compliance with health guidelines? Condition being studied: The association between trust in government and authorities and civic compliance with health guidelines during respiratory epidemics and pandemics. Eligibility criteria: 1. Studies that explore the relationship bet

APA, Harvard, Vancouver, ISO, and other styles

3

Moza, Andreea, Florentina Duica, Panagiotis Antoniadis, et al. Outcome of newborns in case of SARS-CoV-2 vertical infection. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.12.0093.

Full text

Abstract:

Review question / Objective: To identify the types and examine the range of available evidence of vertical transmission of SARS-CoV-2 from mother to newborn. To clarify the key concepts and criteria for diagnosis of SARS-CoV-2 vertical infection in neonates. To summarize the existing evidence and advance the awareness on SARS-CoV-2 vertical infection in pregnancy. Background: Severe Acute Respiratory Syndrome Virus 2 (SARS-CoV-2), the virus that causes 2019 coronavirus disease (COVID-19), has been isolated from various tissues and body fluids, including the placenta, amniotic fluid, and umbili

APA, Harvard, Vancouver, ISO, and other styles

4

Kintz, Erica, Erin Lewis, and Victoria Cohen. Qualitative assessment of the risk of SARS-CoV-2 to human health through food exposures to deer in the UK. Food Standards Agency, 2023. http://dx.doi.org/10.46756/sci.fsa.jip603.

Full text

Abstract:

SARS-CoV-2, the coronavirus responsible for the infectious disease COVID-19 (Gorbalenya et al 2020 (Opens in a new window)), was first detected in the human population in December 2019 (Zhu et al 2020 (Opens in a new window)). It has since spread to become a global pandemic. Previously, two other novel coronaviruses caused illness in the human population. The first, SARS-CoV (for Severe Acute Respiratory Syndrome) was recognised as a new illness in 2004 and the second, MERS-CoV (for Middle East respiratory syndrome) in 2012 (de Wit et al. 2016). These previous coronavirus outbreaks in humans o

APA, Harvard, Vancouver, ISO, and other styles

5

Coronel-Monje, Katiusca, Mayron Antonio Candia-Puma, Juan Jeferson Vilca-Alosilla, et al. A Systematic Review of Peruvian Contributions to Scientific Publications on Experimental Research Against COVID-19. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.4.0080.

Full text

Abstract:

Review question / Objective: The objective of this research work is to evaluate the generation capacity of experimental research carried out in Peru, which will help in making future decisions, both to establish future studies, to elucidate the lack of studies in certain areas, as well as to determine the country's roadmap in a current and future state of emergency. Condition being studied: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first reported in December 2019 in Wuhan, China, and has spread worldwide becoming a pandemic

APA, Harvard, Vancouver, ISO, and other styles

6

Wang, Xiao, Hong Shen, Yujie Liang, Yixin Wang, Meiqi Zhang, and Hongtao Ma. Effects of physical activity interventions for post-COVID-19 patients: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.5.0036.

Full text

Abstract:

Review question / Objective: Coronavirus disease 2019 (COVID-19) is a novel infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has caused a huge impact in many countries and has attracted great attention from countries around the world. However, since the outbreak of the COVID-19 pandemic, most attention has focused on containing transmission and addressing the surge of critically ill patients in acute care settings. As we enter the second phase of the pandemic, emphasis must evolve to post care of COVID-19 survivors. A variety of persistent sympto

APA, Harvard, Vancouver, ISO, and other styles

7

Şeker, Muzaffer, Ali Özer, Zekeriya Tosun, Cem Korkut, and Mürsel Doğrul, eds. The Assessment Report on COVID-19 Global Outbreak. Türkiye Bilimler Akademisi, 2020. http://dx.doi.org/10.53478/tuba.2020.119.

Full text

Abstract:

"In late December 2019, a large number of patients with unknown causes of pneumonia were reported by press from a seafood market in Wuhan, Hubei province, China. This coronavirus was originally named the 2019 new coronavirus (2019-nCoV) by the World Health Organization (WHO) on January 12, 2020. The Coronavirus Working Group (CSG) of the WHO and International Committee proposed to call the new virus SARS-CoV-2 on February 11, 2020. As a result of the samples taken from the patient, the whole genome sequence of the SARS-CoV-2 was isolated on January 7, 2020, by Chinese scientists in a short tim

APA, Harvard, Vancouver, ISO, and other styles

8

Şeker, Muzaffer, Ali Özer, Zekeriya Tosun, Cem Korkut, and Mürsel Doğrul, eds. COVID-19 Küresel Salgın Değerlendirme Raporu. Türkiye Bilimler Akademisi, 2020. http://dx.doi.org/10.53478/tuba.2020.118.

Full text

Abstract:

"In late December 2019, a large number of patients with unknown causes of pneumonia were reported by press from a seafood market in Wuhan, Hubei province, China. This coronavirus was originally named the 2019 new coronavirus (2019-nCoV) by the World Health Organization (WHO) on January 12, 2020. The Coronavirus Working Group (CSG) of the WHO and Internati- onal Committee proposed to call the new virus SARS-CoV-2 on February 11, 2020. As a result of the samples taken from the patient, the whole genome sequence of the SARS-CoV-2 was isolated on January 7, 2020, by Chinese scientists in a short t

APA, Harvard, Vancouver, ISO, and other styles

9

Jenkins, J. Lee, Edbert B. Hsu, Anna Russell, Allen Zhang, Lisa M. Wilson, and Eric B. Bass. Infection Prevention and Control for the Emergency Medical Services and 911 Workforce. Agency for Healthcare Research and Quality (AHRQ), 2022. http://dx.doi.org/10.23970/ahrqepctb42.

Full text

Abstract:

Objectives. To summarize current evidence on exposures to infectious pathogens in the emergency medical services (EMS) and 911 workforce, and on practices for preventing, recognizing, and controlling occupationally acquired infectious diseases and related exposures in that workforce. Review methods. We obtained advice on how to answer four Guiding Questions by recruiting a panel of external experts on EMS clinicians, State-level EMS leadership, and programs relevant to EMS personnel, and by engaging representatives of professional societies in infectious diseases and emergency medicine. We sea

APA, Harvard, Vancouver, ISO, and other styles

10

F, Verdugo-Paiva, Izcovich A, Ragusa M, and Rada G. Lopinavir/ritonavir for the treatment of COVID-19: A living systematic review protocol. Epistemonikos Interactive Evidence Synthesis, 2024. http://dx.doi.org/10.30846/ies.4f3c02f030.

Full text

Abstract:

Objective To assess the efficacy and safety of lopinavir/ritonavir for the treatment of patients with COVID-19. Design This is the protocol of a living systematic review. Data sources We will conduct searches in the [https://app.iloveevidence.com/loves/5e6fdb9669c00e4ac072701d](L.OVE platform for COVID-19), a system that maps PICO questions to a repository maintained through regular searches in electronic databases, preprint servers, trial registries and other resources relevant to COVID-19. No date or language restrictions will be applied. Eligibility criteria for selecting studies and method

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!